Remove laboratory budget, demands German diagnostics industry
This article was originally published in Clinica
As long as the laboratory budget remains in place, which consequently restricts the number of tests carried out by doctors in the outpatient sector, the diagnostics industry will be unable to realise its full potential, says the German industry association for diagnostics (VDGH). Revealing its figures at Medica 2001, the association said that sales of self-tests were almost the only type of diagnostics to have undergone noticeable growth.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.